The White House withdrew its nomination of Dr. Heidi Overton to lead the Food and Drug Administration Tuesday after doubting her ability to win Senate confirmation.
Axios first reported the news and added that Health and Human Services Sec. Robert F. Kennedy Jr. will have to go back to the drawing board and find a suitable pick who can carry out his Make America Healthy Again agenda.
“We need to go in a new direction at FDA, and everybody fully supports Secretary Kennedy’s vision to Make America Healthy Again and get back to a more populist and common-sense approach to health in America,” a senior administration official told the political news outlet.
Overton was slated for a Senate committee vote Wednesday, but lawmakers, including Republicans, raised concerns about her record regarding scaling back vaccine recommendations, according to The Wall Street Journal.
Additionally, her role in scaling back restrictions on vapes and her stance on abortion made members of the upper chamber question her competency.
GOP Sen. Bill Cassidy of Louisiana, a physician and chairman of the Senate health committee, said Tuesday that he thought Overton had the votes to make it over the finish line.
“Tonight, the White House abandoned a viable confirmation path for Dr. Overton,” he wrote on X. “The WH said that this was because she did not have the votes to pass. This was odd as I was having productive conversations with members. I believe she would have had the votes to pass out of committee and pass the full Senate.”
Signing you in…
Please keep this page open. The results will appear here.
Checking your response…
Check your email to count your vote
We sent a confirmation link to .
Click Confirm Your Vote in that email to count your vote and unlock the results.
Your vote has not been counted yet. If the email hasn't arrived, check your spam or junk folder.
“My conversations with her convinced me she would follow the science and push back against decisions that put Americans’ health at risk,” he continued. “The last issue was that pro-life Senators sought final assurances from the Administration regarding the Administration’s commitment to life issues. The Administration withdrew Dr. Overton rather than make such commitments.”
“Unfortunately, with the limited time left, confirming a permanent FDA Commissioner will fall to Senate Democrats,” Cassidy concluded.
The Wall Street Journal noted that Overton, who currently works with the White House’s Domestic Policy Council, faced issues with the MAHA movement for not fully implementing Kennedy’s agenda.
One source said Kennedy spoke with outgoing Republican Sen. Roger Marshall of Kansas about choosing another nominee.
Marshall himself is being considered as a potential replacement, but nothing official has been announced.
A main issue that plagued Overton’s nomination was her drafting of President Donald Trump’s August executive order, which recommended fewer child immunizations.
The order, titled “DELIVERING GOLD STANDARD CHILDHOOD VACCINE RECOMMENDATIONS FOR AMERICANS,” was geared toward “ensuring that Americans are receiving the best scientifically supported medical advice in the world, as well as to protecting religious liberty and parental authority.”
GOP Sen. Josh Hawley of Missouri told reporters Tuesday that despite concerns, Overton impressed him with her answers and that, “Every commitment I asked her to give, she made.”
Politico highlighted how White House officials, including chief of staff Stephen Miller, had talked about pulling Overton’s nomination over the weekend, citing four people with knowledge of the matter.











